These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1903067

  • 1. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
    Urano T, Takada Y, Takada A.
    Biochim Biophys Acta; 1991 Apr 29; 1077(3):245-52. PubMed ID: 1903067
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
    Fischer B.
    Biol Chem Hoppe Seyler; 1990 Nov 29; 371(11):1067-75. PubMed ID: 2128181
    [Abstract] [Full Text] [Related]

  • 3. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jan 29; 300(1):472-82. PubMed ID: 8424682
    [Abstract] [Full Text] [Related]

  • 4. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Urano T, deSerrano VS, Urano S, Castellino FJ.
    Arch Biochem Biophys; 1989 Apr 29; 270(1):356-62. PubMed ID: 2494944
    [Abstract] [Full Text] [Related]

  • 5. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
    Wojta J, Beckmann R, Turcu L, Wagner OF, van Zonneveld AJ, Binder BR.
    J Biol Chem; 1989 May 15; 264(14):7957-61. PubMed ID: 2470738
    [Abstract] [Full Text] [Related]

  • 6. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM, Caban R, Runge MS.
    J Biol Chem; 1993 Mar 15; 268(8):5550-6. PubMed ID: 8449917
    [Abstract] [Full Text] [Related]

  • 7. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
    Nieuwenhuizen W, Voskuilen M, Vermond A, Hoegee-de Nobel B, Traas DW.
    Eur J Biochem; 1988 May 16; 174(1):163-9. PubMed ID: 3131143
    [Abstract] [Full Text] [Related]

  • 8. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL, Chang BI, Wu DH, Chang LC, Gong CC, Lou KL, Shi GY.
    J Biol Chem; 1990 Nov 15; 265(32):19658-64. PubMed ID: 2174048
    [Abstract] [Full Text] [Related]

  • 9. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M, Sakata Y, Matsuda M, Mimuro J.
    J Biochem; 1992 Feb 15; 111(2):244-8. PubMed ID: 1314812
    [Abstract] [Full Text] [Related]

  • 10. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M, Fredenburgh JC, Larsen GR.
    J Biol Chem; 1990 Dec 15; 265(35):21541-8. PubMed ID: 2123871
    [Abstract] [Full Text] [Related]

  • 11. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L.
    Biochemistry; 2000 Dec 26; 39(51):15730-41. PubMed ID: 11123898
    [Abstract] [Full Text] [Related]

  • 12. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB, Ravn P, Berglund L, Petersen TE, Rasmussen LK, Heegaard CW, Rasmussen JT, Benfeldt C, Fedosov SN.
    Biochemistry; 1998 Sep 08; 37(36):12631-9. PubMed ID: 9730836
    [Abstract] [Full Text] [Related]

  • 13. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
    Bergum PW, Gardell SJ.
    J Biol Chem; 1992 Sep 05; 267(25):17726-31. PubMed ID: 1387641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ, Wu YH, Liu CF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan 05; 36(1):62-7. PubMed ID: 19099932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE, Will H.
    Biochim Biophys Acta; 1990 Oct 18; 1041(1):48-54. PubMed ID: 2145980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.